Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study

Overactive Bladder ◽

Prospective Study ◽

Prostatic Hyperplasia ◽

Bladder Symptoms ◽

A Prospective Study

Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia

Urology ◽

10.1016/j.urology.2015.01.028 ◽

2015 ◽

Vol 85 (5) ◽

pp. 1151-1155 ◽

Cited By ~ 10

Author(s):

Takahiro Maeda ◽

Eiji Kikuchi ◽

Masanori Hasegawa ◽

Katsura Ishioka ◽

Masayuki Hagiwara ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

2166 EFFECT OF HOLEP ON OVERACTIVE BLADDER SYMPTOMS AND URODYNAMIC FINDINGS: A PROSPECTIVE STUDY

The Journal of Urology ◽

10.1016/j.juro.2012.02.2339 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

OhSeong Kwon ◽

Jungbum Bae ◽

Hahn-Ey Lee ◽

Seung-June Oh

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Bladder Symptoms ◽

A Prospective Study

Effect of Holmium Laser Enucleation of Prostate on Overactive Bladder Symptoms and Urodynamic Parameters: A Prospective Study

Urology ◽

10.1016/j.urology.2013.10.037 ◽

2014 ◽

Vol 83 (3) ◽

pp. 581-585 ◽

Cited By ~ 15

Author(s):

Ohseong Kwon ◽

Hahn-Ey Lee ◽

Jungbum Bae ◽

Jin Kyu Oh ◽

Seung-June Oh

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Holmium Laser ◽

Bladder Symptoms ◽

Laser Enucleation ◽

A Prospective Study ◽

Urodynamic Parameters ◽

Holmium Laser Enucleation

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

The Journal of Urology ◽

10.1097/01.ju.0000557495.41260.09 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Steven Kaplan* ◽

Sender Herschorn ◽

Kevin McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

International Journal of Urology ◽

10.1111/iju.13359 ◽

2017 ◽

Vol 24 (7) ◽

pp. 525-531 ◽

Cited By ~ 11

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Overactive Bladder ◽

Combination Therapy ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Direct Study ◽

Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12406 ◽

2021 ◽

Author(s):

Dongu Lee ◽

Kyo Chul Koo ◽

Jeong Woo Yoo ◽

Kwang Suk Lee

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

MP-01.01: The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient's satisfaction

Urology ◽

10.1016/j.urology.2010.07.345 ◽

2010 ◽

Vol 76 (3) ◽

pp. S9

Author(s):

W. Cho ◽

T. Kim ◽

J. Yoon

Keyword(s):

Risk Factors ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Patient’S Satisfaction ◽

Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01222.x ◽

2006 ◽

Vol 13 (1) ◽

pp. 15-20 ◽

Cited By ~ 37

Author(s):

SATORU TAKAHASHI ◽

ATSUSHI TAJIMA ◽

HISASHI MATSUSHIMA ◽

TAKESHI KAWAMURA ◽

TAKASHI TOMINAGA ◽

...

Keyword(s):

Overactive Bladder ◽

Clinical Efficacy ◽

Prostatic Hyperplasia ◽

Adrenoceptor Blocker ◽

Outcomes for Intravesical Abobotulinumtoxin A (Dysport) Treatment in the Active Management of Overactive Bladder Symptoms—A Prospective Study

Urology ◽

10.1016/j.urology.2019.04.018 ◽

2019 ◽

Vol 130 ◽

pp. 54-58 ◽

Cited By ~ 2

Author(s):

Marius Craciun ◽

Paul P. Irwin

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Active Management ◽

Bladder Symptoms ◽

A Prospective Study

Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

Urology ◽

10.1016/j.urology.2020.09.040 ◽

2021 ◽

Vol 147 ◽

pp. 235-242

Author(s):

Sender Herschorn ◽

Kevin T. McVary ◽

Javier Cambronero Santos ◽

Steve Foley ◽

Rita M. Kristy ◽

...

Keyword(s):

Overactive Bladder ◽

Safety Analysis ◽

Prostatic Hyperplasia ◽